ArticleInflammopharmacology2025

Casticin reduces rosacea-related inflammation by inhibiting mast cell activation via Mas-related G protein-coupled receptor X2.

Tao Jia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.